1,2-dichloroethane decreases expression ISO RGD:1552280 6480464 ethylene dichloride results in decreased expression of NEFL mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1552280 6480464 1, 2-Dimethylhydrazine results in decreased expression of NEFL mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1552280 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEFL mRNA CTD PMID:17942748 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1552280 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1552280 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552280 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEFL mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NEFL mRNA CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1552280 6480464 2 more ... CTD PMID:18550172 2,5-hexanedione decreases expression EXP 6480464 2, 5-hexanedione results in decreased expression of NEFL protein CTD PMID:19033394 more ... 2,5-hexanedione multiple interactions EXP 6480464 Glyburide inhibits the reaction [2, 5-hexanedione results in decreased expression of NEFL protein] CTD PMID:32522579 , PMID:32860822 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein], Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] CTD PMID:21863293 , PMID:21879721 2-methylcholine affects expression ISO RGD:1344238 6480464 beta-methylcholine affects the expression of NEFL mRNA CTD PMID:21179406 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:1552280 6480464 Triiodothyronine results in decreased expression of NEFL mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NEFL protein CTD PMID:26068050 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344238 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of NEFL mRNA CTD PMID:29698629 3-methyladenine multiple interactions ISO RGD:1344238 6480464 3-methyladenine inhibits the reaction [tri-o-cresyl phosphate results in decreased expression of NEFL protein] CTD PMID:23743148 5-azacytidine increases expression ISO RGD:1344238 6480464 Azacitidine results in increased expression of NEFL mRNA CTD PMID:20823114 6-Cyano-7-nitroquinoxaline-2,3-dione multiple interactions EXP 6480464 6-Cyano-7-nitroquinoxaline-2 more ... CTD PMID:21863293 , PMID:31969611 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NEFL mRNA CTD PMID:24780913 9-cis-retinoic acid decreases expression ISO RGD:1344238 6480464 Alitretinoin results in decreased expression of NEFL mRNA CTD PMID:15982314 acetamide increases expression EXP 6480464 acetamide results in increased expression of NEFL mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NEFL mRNA, Acrylamide results in increased expression of NEFL protein CTD PMID:10678756 acrylamide multiple interactions EXP 6480464 NGF protein promotes the reaction [Acrylamide results in increased expression of NEFL protein] CTD PMID:10678756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NEFL mRNA CTD PMID:23630614 aflatoxin B1 increases expression ISO RGD:1344238 6480464 Aflatoxin B1 results in increased expression of NEFL mRNA CTD PMID:32234424 aldrin increases expression ISO RGD:1552280 6480464 Aldrin results in increased expression of NEFL mRNA CTD PMID:18579281 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1344238 6480464 4-oxoretinoic acid results in decreased expression of NEFL mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1344238 6480464 Tretinoin metabolite results in decreased expression of NEFL mRNA, Tretinoin results in decreased expression of NEFL mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:1344238 6480464 Tretinoin results in increased expression of NEFL mRNA, Tretinoin results in increased expression of NEFL protein CTD PMID:21934132 , PMID:26498558 all-trans-retinoic acid multiple interactions ISO RGD:1344238 6480464 [Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of NEFL protein CTD PMID:17085092 aluminium sulfate (anhydrous) decreases expression ISO RGD:1344238 6480464 aluminum sulfate results in decreased expression of NEFL mRNA CTD PMID:15961160 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NEFL mRNA CTD PMID:16483693 antimycin A decreases expression ISO RGD:1344238 6480464 Antimycin A results in decreased expression of NEFL mRNA CTD PMID:33512557 arsane affects expression ISO RGD:1344238 6480464 Arsenic metabolite affects the expression of NEFL mRNA CTD PMID:17553662 arsenic atom affects expression ISO RGD:1344238 6480464 Arsenic metabolite affects the expression of NEFL mRNA CTD PMID:17553662 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of NEFL protein CTD PMID:18242949 arsenite(3-) increases methylation ISO RGD:1344238 6480464 arsenite results in increased methylation of NEFL promoter CTD PMID:23974009 atrazine increases expression ISO RGD:1344238 6480464 Atrazine results in increased expression of NEFL mRNA CTD PMID:22378314 azoxystrobin decreases expression ISO RGD:1344238 6480464 azoxystrobin results in decreased expression of NEFL mRNA CTD PMID:33512557 BAPTA multiple interactions EXP 6480464 1 more ... CTD PMID:31969611 belinostat increases expression ISO RGD:1344238 6480464 belinostat results in increased expression of NEFL mRNA CTD PMID:26272509 Benzamil multiple interactions EXP 6480464 benzamil inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 benzo[a]pyrene multiple interactions ISO RGD:1552280 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to NEFL promoter] CTD PMID:19654925 benzo[a]pyrene decreases methylation ISO RGD:1344238 6480464 Benzo(a)pyrene results in decreased methylation of NEFL 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1344238 6480464 Benzo(a)pyrene results in increased methylation of NEFL 5' UTR, Benzo(a)pyrene results in increased methylation of NEFL promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1344238 6480464 Benzo(a)pyrene affects the methylation of NEFL exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1344238 6480464 Benzo(a)pyrene results in increased expression of NEFL mRNA CTD PMID:22316170 , PMID:32234424 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NEFL mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1552280 6480464 bisphenol A results in increased expression of NEFL mRNA, bisphenol A results in increased expression of NEFL protein CTD PMID:31574244 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of NEFL protein CTD PMID:28903499 bucladesine multiple interactions ISO RGD:1344238 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of NEFL mRNA CTD PMID:29698629 butanal increases expression ISO RGD:1344238 6480464 butyraldehyde results in increased expression of NEFL mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 calcitriol decreases expression ISO RGD:1344238 6480464 Calcitriol results in decreased expression of NEFL mRNA CTD PMID:16002434 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] more ... CTD PMID:11071371 , PMID:21879721 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] more ... CTD PMID:11071371 , PMID:21879721 Calpeptin multiple interactions EXP 6480464 calpeptin inhibits the reaction [Calcium results in increased degradation of NEFL protein] CTD PMID:11071371 calyculin a multiple interactions EXP 6480464 calyculin A inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein] CTD PMID:21863293 carbon disulfide decreases expression EXP 6480464 Carbon Disulfide results in decreased expression of NEFL protein CTD PMID:16474999 , PMID:17120161 carbon disulfide increases expression EXP 6480464 Carbon Disulfide results in increased expression of NEFL mRNA, Carbon Disulfide results in increased expression of NEFL protein CTD PMID:17120161 , PMID:19165470 chloroethene increases expression ISO RGD:1552280 6480464 Vinyl Chloride results in increased expression of NEFL mRNA CTD PMID:18579281 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of NEFL mRNA, Chlorpyrifos results in increased expression of NEFL protein CTD PMID:18812211 , PMID:34058248 chlorpyrifos increases expression ISO RGD:1552280 6480464 Chlorpyrifos results in increased expression of NEFL mRNA CTD PMID:26018426 choline multiple interactions ISO RGD:1552280 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEFL gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of NEFL mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1344238 6480464 Cisplatin results in increased expression of NEFL mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1344238 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of NEFL mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of NEFL mRNA] CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1344238 6480464 cobaltous chloride results in increased expression of NEFL mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of NEFL mRNA CTD PMID:18375950 cocaine affects expression EXP 6480464 Cocaine affects the expression of NEFL mRNA CTD PMID:20187946 cocaine decreases expression ISO RGD:1344238 6480464 Cocaine results in decreased expression of NEFL mRNA CTD PMID:12629581 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of NEFL mRNA CTD PMID:16076954 copper atom multiple interactions ISO RGD:1344238 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NEFL mRNA CTD PMID:20971185 copper atom multiple interactions ISO RGD:1552280 6480464 MT1 affects the reaction [Copper results in increased expression of NEFL mRNA], MT2 affects the reaction [Copper results in increased expression of NEFL mRNA] CTD PMID:16629173 copper(0) multiple interactions ISO RGD:1344238 6480464 [NSC 689534 binds to Copper] which results in decreased expression of NEFL mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1552280 6480464 MT1 affects the reaction [Copper results in increased expression of NEFL mRNA], MT2 affects the reaction [Copper results in increased expression of NEFL mRNA] CTD PMID:16629173 copper(II) chloride decreases expression ISO RGD:1552280 6480464 cupric chloride results in decreased expression of NEFL protein CTD PMID:29617964 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of NEFL mRNA CTD PMID:26577399 cycloheximide decreases expression EXP 6480464 Cycloheximide results in decreased expression of NEFL mRNA CTD PMID:19146868 cyfluthrin decreases expression ISO RGD:1344238 6480464 cyfluthrin results in decreased expression of NEFL mRNA CTD PMID:32028016 cypermethrin decreases expression ISO RGD:1344238 6480464 cypermethrin results in decreased expression of NEFL mRNA CTD PMID:32028016 daidzein 7-O-beta-D-glucoside increases expression EXP 6480464 daidzin results in increased expression of NEFL mRNA, daidzin results in increased expression of NEFL protein CTD PMID:31034797 dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein], Dantrolene inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] CTD PMID:21863293 , PMID:21879721 deguelin decreases expression ISO RGD:1344238 6480464 deguelin results in decreased expression of NEFL mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:1344238 6480464 Dexamethasone results in increased expression of NEFL mRNA CTD PMID:25047013 dibutyl phthalate decreases expression ISO RGD:1552280 6480464 Dibutyl Phthalate results in decreased expression of NEFL mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 dichlorvos decreases expression EXP 6480464 Dichlorvos results in decreased expression of NEFL mRNA CTD PMID:19146868 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of NEFL mRNA CTD PMID:18812211 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of NEFL mRNA CTD PMID:17005392 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NEFL mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of NEFL mRNA CTD PMID:21551480 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein] more ... CTD PMID:21863293 , PMID:31969611 dorsomorphin multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1344238 6480464 Doxorubicin results in increased expression of NEFL mRNA CTD PMID:25529476 more ... endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NEFL mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1344238 6480464 entinostat results in increased expression of NEFL mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:1344238 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NEFL protein CTD PMID:23301498 ethanol affects expression ISO RGD:1552280 6480464 Ethanol affects the expression of NEFL mRNA CTD PMID:15513904 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NEFL protein CTD PMID:16770775 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:21879721 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of NEFL mRNA CTD PMID:30307764 folic acid multiple interactions ISO RGD:1552280 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEFL gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1552280 6480464 Folic Acid results in decreased expression of NEFL mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of NEFL mRNA CTD PMID:25539665 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NEFL mRNA CTD PMID:33387578 glyburide multiple interactions EXP 6480464 Glyburide inhibits the reaction [2, 5-hexanedione results in decreased expression of NEFL protein] CTD PMID:32522579 , PMID:32860822 Heptachlor epoxide decreases expression ISO RGD:1552280 6480464 Heptachlor Epoxide results in decreased expression of NEFL mRNA CTD PMID:25270620 hydrogen sulfide decreases expression ISO RGD:1552280 6480464 Hydrogen Sulfide results in decreased expression of NEFL protein CTD PMID:29932956 idebenone multiple interactions EXP 6480464 idebenone inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [Calcium results in increased degradation of NEFL protein] CTD PMID:11071371 isotretinoin decreases expression ISO RGD:1344238 6480464 Isotretinoin results in decreased expression of NEFL mRNA CTD PMID:15982314 ivermectin decreases expression ISO RGD:1344238 6480464 Ivermectin results in decreased expression of NEFL protein CTD PMID:32959892 kainic acid increases secretion EXP 6480464 Kainic Acid results in increased secretion of NEFL protein CTD PMID:34677616 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of NEFL protein CTD PMID:18504422 ketamine increases expression EXP 6480464 Ketamine results in increased expression of NEFL mRNA CTD PMID:20080153 KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] CTD PMID:21879721 L-methionine multiple interactions ISO RGD:1552280 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEFL gene CTD PMID:20938992 lead diacetate increases expression ISO RGD:1552280 6480464 lead acetate results in increased expression of NEFL protein CTD PMID:20797405 leupeptin multiple interactions ISO RGD:1344238 6480464 leupeptin inhibits the reaction [CTSB protein results in increased degradation of NEFL protein] CTD PMID:11071371 manganese atom increases expression ISO RGD:1552280 6480464 Manganese results in increased expression of NEFL protein CTD PMID:22191580 manganese atom multiple interactions ISO RGD:1552280 6480464 HTT protein mutant form inhibits the reaction [Manganese results in increased expression of NEFL protein] CTD PMID:22191580 manganese(0) increases expression ISO RGD:1552280 6480464 Manganese results in increased expression of NEFL protein CTD PMID:22191580 manganese(0) multiple interactions ISO RGD:1552280 6480464 HTT protein mutant form inhibits the reaction [Manganese results in increased expression of NEFL protein] CTD PMID:22191580 manganese(II) chloride decreases expression ISO RGD:1552280 6480464 manganese chloride results in decreased expression of NEFL mRNA CTD PMID:15295902 memantine multiple interactions EXP 6480464 Memantine inhibits the reaction [N-Methylaspartate results in decreased expression of NEFL mRNA], Memantine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 mercury dibromide increases expression ISO RGD:1344238 6480464 mercuric bromide results in increased expression of NEFL mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 methylmercury chloride affects expression ISO RGD:1552280 6480464 methylmercuric chloride affects the expression of NEFL mRNA CTD PMID:21613230 methylmercury chloride increases expression ISO RGD:1344238 6480464 methylmercuric chloride results in increased expression of NEFL mRNA CTD PMID:23179753 , PMID:28001369 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of NEFL mRNA CTD PMID:19651682 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 N-methyl-D-aspartic acid multiple interactions EXP 6480464 3-(2-((phenylamino)carbonyl)ethenyl)-4 more ... CTD PMID:31969611 N-methyl-D-aspartic acid decreases expression EXP 6480464 N-Methylaspartate results in decreased expression of NEFL mRNA CTD PMID:31969611 N-Nitrosopyrrolidine increases expression ISO RGD:1344238 6480464 N-Nitrosopyrrolidine results in increased expression of NEFL mRNA CTD PMID:32234424 nicardipine multiple interactions EXP 6480464 Nicardipine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein] CTD PMID:21863293 Nilvadipine multiple interactions EXP 6480464 nilvadipine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 O-methyleugenol increases expression ISO RGD:1344238 6480464 methyleugenol results in increased expression of NEFL mRNA CTD PMID:32234424 ouabain decreases expression ISO RGD:1344238 6480464 Ouabain results in decreased expression of NEFL mRNA CTD PMID:28795476 panobinostat increases expression ISO RGD:1344238 6480464 panobinostat results in increased expression of NEFL mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NEFL mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of NEFL mRNA, Paraquat results in decreased expression of NEFL protein CTD PMID:19146868 , PMID:24521700 parathion decreases expression EXP 6480464 Parathion results in decreased expression of NEFL mRNA CTD PMID:19146868 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:21673325 PCB138 multiple interactions ISO RGD:1552280 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:1344238 6480464 pentanal results in increased expression of NEFL mRNA CTD PMID:26079696 phenylmercury acetate increases expression ISO RGD:1344238 6480464 Phenylmercuric Acetate results in increased expression of NEFL mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 picoxystrobin decreases expression ISO RGD:1344238 6480464 picoxystrobin results in decreased expression of NEFL mRNA CTD PMID:33512557 propanal increases expression ISO RGD:1344238 6480464 propionaldehyde results in increased expression of NEFL mRNA CTD PMID:26079696 pyridoxine increases secretion EXP 6480464 Pyridoxine results in increased secretion of NEFL protein CTD PMID:34677616 raloxifene affects expression ISO RGD:1344238 6480464 Raloxifene Hydrochloride affects the expression of NEFL mRNA CTD PMID:14699072 rotenone increases expression ISO RGD:1344238 6480464 Rotenone results in increased expression of NEFL mRNA CTD PMID:33512557 rotenone multiple interactions EXP 6480464 1 more ... CTD PMID:31969611 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NEFL mRNA CTD PMID:31969611 SB 431542 multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions ISO RGD:1344238 6480464 [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of NEFL promoter CTD PMID:18448484 sodium arsenite affects expression ISO RGD:1344238 6480464 sodium arsenite affects the expression of NEFL mRNA CTD PMID:29319823 , PMID:34032870 sodium arsenite increases expression ISO RGD:1344238 6480464 sodium arsenite results in increased expression of NEFL mRNA CTD PMID:28595984 sodium arsenite multiple interactions EXP 6480464 sodium arsenite results in decreased expression of and results in increased phosphorylation of NEFL protein CTD PMID:18674524 sodium arsenite increases expression ISO RGD:1552280 6480464 sodium arsenite results in increased expression of NEFL mRNA CTD PMID:23022324 , PMID:28370166 sodium arsenite decreases expression ISO RGD:1344238 6480464 sodium arsenite results in decreased expression of NEFL mRNA CTD PMID:18448484 Soman increases expression EXP 6480464 Soman results in increased expression of NEFL mRNA CTD PMID:19281266 staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] CTD PMID:21879721 sunitinib increases expression ISO RGD:1344238 6480464 Sunitinib results in increased expression of NEFL mRNA CTD PMID:31533062 tebufenpyrad decreases expression ISO RGD:1344238 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of NEFL mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:1344238 6480464 Temozolomide results in increased expression of NEFL mRNA CTD PMID:31758290 terbutaline increases expression EXP 6480464 Terbutaline results in increased expression of NEFL protein CTD PMID:14610225 tetrachloroethene decreases expression EXP 6480464 Tetrachloroethylene results in decreased expression of NEFL protein CTD PMID:8372046 thifluzamide decreases expression ISO RGD:1344238 6480464 thifluzamide results in decreased expression of NEFL mRNA CTD PMID:33512557 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NEFL mRNA CTD PMID:23411599 , PMID:34492290 Tributyltin oxide decreases expression ISO RGD:1552280 6480464 bis(tri-n-butyltin)oxide results in decreased expression of NEFL mRNA CTD PMID:25270620 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NEFL mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1344238 6480464 trichostatin A results in increased expression of NEFL mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1344238 6480464 Triclosan results in decreased expression of NEFL mRNA CTD PMID:30510588 trifluoperazine multiple interactions EXP 6480464 Trifluoperazine inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA] CTD PMID:31969611 trimethyltin increases secretion EXP 6480464 trimethyltin results in increased secretion of NEFL protein CTD PMID:34677616 U-73122 multiple interactions EXP 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:21879721 uranium atom affects expression ISO RGD:1344238 6480464 Uranium affects the expression of NEFL mRNA CTD PMID:15672453 valproic acid decreases expression ISO RGD:1552280 6480464 Valproic Acid results in decreased expression of NEFL mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:1344238 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEFL mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1344238 6480464 Valproic Acid results in increased expression of NEFL mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1552280 6480464 Valproic Acid affects the expression of NEFL mRNA CTD PMID:17292431 , PMID:26072468 valproic acid affects expression ISO RGD:1344238 6480464 Valproic Acid affects the expression of NEFL mRNA CTD PMID:25979313 , PMID:26072468 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of NEFL mRNA CTD PMID:19651682 verapamil multiple interactions EXP 6480464 Verapamil inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein], Verapamil inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] CTD PMID:21863293 , PMID:21879721 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NEFL mRNA CTD PMID:20566332 vorinostat increases expression ISO RGD:1344238 6480464 vorinostat results in increased expression of NEFL mRNA CTD PMID:26272509 Z-Val-Phe-H multiple interactions EXP 6480464 calpain inhibitor III inhibits the reaction [Zymosan results in increased degradation of NEFL protein] CTD PMID:15275793 zoledronic acid decreases expression ISO RGD:1344238 6480464 zoledronic acid results in decreased expression of NEFL mRNA CTD PMID:24714768
